News Quantified

MDLN – medline inc. - class a common stock (US:NASDAQ)

Medline (NASDAQ:MDLN) is now covered by analysts at Tigress Financial. They set a "buy" rating and a $55.00 price target on the stock.

1/28

09:00 am

mdln

Medium

Medline to report fourth quarter and full year 2025 results on February 25, 2026

Baillie Gifford's Strategic Moves: Cloudflare Inc. Reduction by 23% [Yahoo! Finance]

Medline (NASDAQ:MDLN) was given a new $55.00 price target on by analysts at JPMorgan Chase & Co..

Medline (NASDAQ:MDLN) had its "buy" rating reaffirmed by analysts at BTIG Research.

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}